Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Radnor, Pennsylvania, focused on developing innovative therapies for hypertension and related cardiovascular conditions. The company's robust pipeline is designed to address significant unmet medical needs in this sector, reflecting its dedication to enhancing patient care and treatment outcomes. With a strategic emphasis on advancing its drug candidates and a commitment to transforming the therapeutic landscape for chronic cardiovascular diseases, Mineralys presents an attractive opportunity for institutional investors seeking to engage with pioneering advancements in healthcare. Show more

Location: 150 N. RADNOR CHESTER RD., RADNOR, PA, UNITED STATES, 19087, Radnor, PA, 19087, USA | Website: https://mineralystx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

2.233B

52 Wk Range

$8.24 - $47.65

Previous Close

$28.21

Open

$28.98

Volume

1,280,451

Day Range

$28.42 - $30.19

Enterprise Value

1.83B

Cash

217.6M

Avg Qtr Burn

-28.87M

Insider Ownership

1.50%

Institutional Own.

-

Qtr Updated

09/30/25